(Health-NewsWire.Net, November 26, 2017 ) Overview of Endometriosis Market:
According to top market analysts, the worldwide Endometriosis Market is estimated to be USD 1.91 Billion by 2023 at a CAGR of 1.33%. Lupron, developed by Abbvie is the top selling drug of Endometriosis contributing to majority of the market size. Other top players include Visanne / Dienogest (Bayer Healthcare), Zoladex (AstraZeneca), Synarel (Pfizer) and Depo-SubQ Provera (Pfizer).
The “Endometriosis - Market Insights, Epidemiology and Market Forecast-2023” research report provides an overview of the disease and global market size of the Endometriosis for the 7MM (United States, EU5 (France, Germany, Italy, Spain and UK) and Japan. It also includes global historical and forecasted epidemiological data for the prevalent, diagnosed and treatable cases of Endometriosis from 2013-2023.
Get a Sample Copy of this Report @ https://www.precisemarketreports.com/report/sample/pmr-62591 .
Endometriosis is the abnormal growth of endometrial tissue similar to that which lines the interior of the uterus, but in a location outside of the uterus. It is usually developed in Peritoneum, fallopian tubes, Ovaries, Cul-de-sac (the space behind the uterus), Outer surfaces of the uterus, bladder, ureters, intestines, and rectum.
Worldwide in 2012, 527,600 women were diagnosed with Endometriosis. The mortality rate was 1.7 to 2.4 per 100,000 women. In the United States, as with other developed countries Endometriosis was the most common gynecologic malignancy, with over 60,000 new cases and over 10,000 deaths from the disease in each year.
Get a 20% Discount on Single User report spread across 85 pages @ https://www.precisemarketreports.com/report/discount/pmr-62591 .
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Key Coverage:
1. Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options. 2. Marketed information including available prescription drugs, its patent and exclusivity details. 3. The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5 and Japan from 2013-2023. 4. It also provides Market size of Endometriosis for United States, EU5 and Japan from 2013 and forecasted Market size to 2023.
To know more click here -> https://www.precisemarketreports.com/report/enquiry/pmr-62591 .
Major Points in Table of Contents:
Global Endometriosis Market Report 2017 1. Report Introduction 2. Endometriosis Market Overview at a Glance 3. Endometriosis 4. Epidemiology and Patient Population 5. Treatment Algorithm 6. Marketed Drugs for Endometriosis 7. Emerging Therapies 8. Overview of Total Endometriosis Market (2016 & 2025) 9. Endometriosis: Country-Wise Market Analysis 10. Market Drivers 11. Market Restraints 12. Appendix 13. Report Methodology 14. Consulting Services 15. Disclaimer
About us: Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario. Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us: Precise Market Reports Office No. 48, Akshya Complex, Dhole Patil road, Maharashtra, Pune – 411001 India. sales@precisemarketreports.com +1 (323) 744 6588 https://www.precisemarketreports.com
Precise Market Reports
Parag Pingale
+1 (323) 744 6588
sales@precisemarketreports.com
Source: EmailWire.Com
|